Research programme: trimerised human growth hormone - Borean PharmaAlternative Names: Trimeric somatropin analogues - Borean Pharma
Latest Information Update: 09 Aug 2007
At a glance
- Originator Borean Pharma
- Mechanism of Action Somatotropin receptor agonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- Discontinued Growth disorders
Most Recent Events
- 09 Aug 2007 Discontinued - Preclinical for Growth disorders in Denmark (unspecified route)
- 27 Feb 2004 Preclinical trials in Growth disorders in Denmark (unspecified route)